Indeed, a genome-wide CRISPR-Cas9-based inactivation screen in OSCC cells led to identifying YAP or TAZ dependency in the majority of HNSCC cell lines [114], validating targeting this pathway. This evidence concerns the gene YAP1 and head and neck squamous cell carcinoma.